TY - JOUR
T1 - Transcriptional Control by NF-kappa B
T2 - Elongation in Focus
AU - Diamant, Gil
AU - Dikstein, Rivka
N1 - Israel Science Foundation [816/09]; Israel Cancer Research Fund; Israel Cancer AssociationWe would like to thank Shaked Ashkenazi for her suggestions and the anonymous referees for their comments and advise. This work was supported by grants from the Israel Science Foundation (#816/09), Israel Cancer Research Fund and Israel Cancer Association. R.D. is the incumbent of the Ruth and Leonard Simon Chair of Cancer Research.
PY - 2013/9
Y1 - 2013/9
N2 - The NF-kappa B family of transcription factors governs the cellular reaction to a variety of extracellular signals. Following stimulation, NF-kappa B activates genes involved in inflammation, cell survival, cell cycle, immune cell homeostasis and more. This review focuses on studies of the past decade that uncover the transcription elongation process as a key regulatory stage in the activation pathway of NF-kappa B. Of interest are studies that point to the elongation phase as central to the selectivity of target gene activation by NF-kappa B. Particularly, the cascade leading to phosphorylation and acetylation of the NF-kappa B subunit p65 on serine 276 and lysine 310, respectively, was shown to mediate the recruitment of Brd4 and P-TEFb to many pro-inflammatory target genes, which in turn facilitate elongation and mRNA processing. On the other hand, some anti-inflammatory genes are refractory to this pathway and are dependent on the elongation factor DSIF for efficient elongation and rnRNA processing. While these studies have advanced our knowledge of NF-kappa B transcriptional activity, they have also raised unresolved issues regarding the specific genomic and physiological contexts by which NF-kappa B utilizes different mechanisms for activation. (c) 2013 Elsevier B.V. All rights reserved.
AB - The NF-kappa B family of transcription factors governs the cellular reaction to a variety of extracellular signals. Following stimulation, NF-kappa B activates genes involved in inflammation, cell survival, cell cycle, immune cell homeostasis and more. This review focuses on studies of the past decade that uncover the transcription elongation process as a key regulatory stage in the activation pathway of NF-kappa B. Of interest are studies that point to the elongation phase as central to the selectivity of target gene activation by NF-kappa B. Particularly, the cascade leading to phosphorylation and acetylation of the NF-kappa B subunit p65 on serine 276 and lysine 310, respectively, was shown to mediate the recruitment of Brd4 and P-TEFb to many pro-inflammatory target genes, which in turn facilitate elongation and mRNA processing. On the other hand, some anti-inflammatory genes are refractory to this pathway and are dependent on the elongation factor DSIF for efficient elongation and rnRNA processing. While these studies have advanced our knowledge of NF-kappa B transcriptional activity, they have also raised unresolved issues regarding the specific genomic and physiological contexts by which NF-kappa B utilizes different mechanisms for activation. (c) 2013 Elsevier B.V. All rights reserved.
U2 - https://doi.org/10.1016/j.bbagrm.2013.04.007
DO - https://doi.org/10.1016/j.bbagrm.2013.04.007
M3 - مقالة مرجعية
SN - 1874-9399
VL - 1829
SP - 937
EP - 945
JO - Biochimica Et Biophysica Acta-Gene Regulatory Mechanisms
JF - Biochimica Et Biophysica Acta-Gene Regulatory Mechanisms
IS - 9
ER -